The new ABPI/BHBIA Guidance notes on collecting adverse events, product complaints and special reporting situations during market research were published on 14 August 2018. The ABPI Pharmacovigilance Expert Network (PEN) have worked very closely with the British Healthcare Business Intelligence...
With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it’s important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.
Following the news that the UK has succeeded in eliminating measles, Dr Emma St Clair Pearce, the ABPI’s newly appointed Research and Collaboration Policy Officer, writes that while the UK’s success of limiting the spread of the virus through vaccination should be heralded, national figures for MMR...
Pharmaceutical companies are increasingly working in partnership with other firms, academia, and catapults through collaborative models, in the search to discover and develop new medicines, says a new report out today.
On Wednesday 21 February, Health and Social Care Secretary Jeremy Hunt announced that Baroness Julia Cumberlege will lead a review into how the NHS responds to safety concerns raised by patients about medicines or medical devices.
This week the Health Research Authority and National Institute for Health Research jointly published a report of the general public's attitudes towards health research.
The pharmaceutical industry typically employs doctors in very distinctive roles which can be related broadly to the medical responsibilities. Each role requires appropriate qualifications. Larger companies often employ specialists while, in smaller companies, some or all of the roles may be combined...
Medicines development is the process of formulating, testing and evaluating a potential new medicine as it moves from the laboratory to the clinic. Chemists, biologists and pharmacologists with a research science background usually undertake early research.
The majority of companies require physicians to be licensed with the General Medical Council (GMC) for entry into the industry, particularly in medical affairs roles.
Should pharmaceutical physicians wish to change career course in the industry, there are various opportunities to explore. This is where experience of different areas (e.g. pharmacovigilance and medical affairs) can be beneficial.